Startups
Harness Therapeutics
Develops RNA-targeted therapeutics that modulate protein levels in the central nervous system to treat Huntington’s disease, Parkinson’s disease, Alzheimer’s disease and ALS. The company was previously called Transine Therapeutics.
Team
Aleksandra PiteraPrincipal Scientist |
Anne RosserClinical Adviser |
Becky JohnsonPrincipal Scientist |
 Christian JungInvestor Director |
Darci BirdResearch Scientist |
Eric MarcussonScientific Adviser |
Ewan BaldwinOperations Manager |
Fay HumphriesResearch Scientist |
Giulia FurlanSenior Scientist |
Haruhito TsutsuiBoard Observer |
 Heather PrestonBoard Chair |
Irina AntonijevicClinical Advisory Board Chair |
Isabela NavarroPrincipal Scientist |
Izzy ThurstonResearch Scientist |
Jeffrey LongClinical Adviser |
Jennifer SimsScientific Adviser |
Jim GusellaScientific Adviser |
Laura BlackburnBioinformatician |
Laura HeratyResearch Scientist |
Mandy CowlingEA, Office Manager and HR Lead |
Marc WatsonResearch Director |
Mary CanningBoard Observer |
Ralf ReilmannClinical Adviser |
Roger BarkerClinical Adviser |
Sarah TabriziClinical Adviser |
Sinem AtliResearch Scientist |
Tom BristonResearch Director |
Tom MasseyScientific Adviser |
Vadim ShchepachevSenior Scientist |
Wendy WilliamsResearch PM |
William GrayClinical Adviser |
Yi-Fang WangPrincipal Scientist |
Yvonne StephensLaboratory Ops Supervisor |
Zara Van VerreResearch Scientist |